{"id":5517,"date":"2018-08-03T08:29:23","date_gmt":"2018-08-03T05:29:23","guid":{"rendered":"http:\/\/bwell-swiss.ch\/?p=5517"},"modified":"2018-08-03T08:29:23","modified_gmt":"2018-08-03T05:29:23","slug":"b-well-is-recommended-by-pulmonologists","status":"publish","type":"post","link":"https:\/\/bwell-swiss.ch\/ng\/news\/b-well-is-recommended-by-pulmonologists\/","title":{"rendered":"B.Well nebulizers clinically tested and recommended by Medical University of St.Petersburg"},"content":{"rendered":"<p>B.Well nebulizers PRO-110, PRO-115, MED-121, MED-125 have been tested by First Pavlov State Medical University of St. Petersburg (Russia). The purpose of this medical research was to compare the effectiveness of asthma treatment:<br \/>\n &#8211; Nebulizer steroid and mucolytic therapy with devices B.Well PRO-110, PRO-115, MED-121, MED-125 (steroid and oral mucolytic);<br \/>\n &#8211; Intravenous steroid therapy and oral mucolytic therapy.<\/p>\n<p> Effectiveness of nebulizer therapy is comparable with intravenous steroid and oral mucolytic hospital therapy. Nebulization therapy with B.Well devices is superior to intravenous steroid therapy and oral mucolytic therapy:\u00a0<br \/>\n &#8211; Nebulized medication delivery is less toxic than intravenous or oral medication;<br \/>\n &#8211; Nebulizers are suitable for people with GI diseases;<br \/>\n &#8211; Nebulizers are suitable for all age and gender groups;<br \/>\n &#8211; Nebulizers are available for self-treatment at home.<\/p>\n<p> Nebulization therapy is an important means of treating patients with asthma. Continuous nebulization therapy improves well-being and reduces the usage of emergency inhalers for patients with asthma.\u00a0B.Well nebulizers PRO-110, PRO-115, MED-121, MED-125 are effective devices which are recommended for both home and hospital usage.<\/p>\n<p> B.Well \u2013 the right devices for caring and protecting the health of your family!<\/p>\n<p>&nbsp;<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-2987 aligncenter\" src=\"http:\/\/bwell-swiss.ch\/wp-content\/uploads\/2017\/12\/MED-125.jpg\" alt=\"\" width=\"350\" height=\"350\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>B.Well nebulizers PRO-110, PRO-115, MED-121, MED-125 have been tested by First Pavlov State Medical University of St. Petersburg (Russia). The purpose of this medical research was to compare the effectiveness of asthma treatment: &#8211; Nebulizer steroid and mucolytic therapy with devices B.Well PRO-110, PRO-115, MED-121, MED-125 (steroid and oral mucolytic); &#8211; Intravenous steroid therapy and [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[195,185],"tags":[193,194,184],"class_list":["post-5517","post","type-post","status-publish","format-standard","hentry","category-ingalyatory","category-news","tag-asthma-treatment","tag-catalogue_nebulizers","tag-news"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/bwell-swiss.ch\/ng\/wp-json\/wp\/v2\/posts\/5517","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bwell-swiss.ch\/ng\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bwell-swiss.ch\/ng\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bwell-swiss.ch\/ng\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/bwell-swiss.ch\/ng\/wp-json\/wp\/v2\/comments?post=5517"}],"version-history":[{"count":0,"href":"https:\/\/bwell-swiss.ch\/ng\/wp-json\/wp\/v2\/posts\/5517\/revisions"}],"wp:attachment":[{"href":"https:\/\/bwell-swiss.ch\/ng\/wp-json\/wp\/v2\/media?parent=5517"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bwell-swiss.ch\/ng\/wp-json\/wp\/v2\/categories?post=5517"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bwell-swiss.ch\/ng\/wp-json\/wp\/v2\/tags?post=5517"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}